FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:957-958 April 6, 1995 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Esrig, D.

To the Editor: Esrig and colleagues (Nov. 10 issue)¹ demonstrate that the immunohistochemical detection of p53 protein in bladder-tumor cells predicts the progression of disease independently of the tumor stage and histologic grade and correlates with an increased risk of recurrent tumor and mortality. This work, combined with recent advances such as the purification of angiostatin, an endogenous inhibitor of tumor angiogenesis,² foreshadows a new approach to identifying patients at high risk for recurrence and metastases, especially when lymph nodes appear to be uninvolved and when surgical resection of the primary tumor suggests an initial cure. Such patients may benefit . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.